Every SEC filing alert our engine sent, newest first: 8-K material events, deals, capital raises, leadership changes, results and insider buying and selling.
Enhanced Group Signs $15M M&A Deal with DEAG Deutsche Entertainment AG
Enhanced Group Inc. has entered into definitive exchange agreements to acquire an approximately 77% controlling interest in DEAG Deutsche Entertainment AG, a Berlin-headquartered live entertainment and ticketing platform. The all-stock transaction involves the issuance of approximately 11 million shares of Class A common stock at a value of $8 per share, complemented by a concurrent $15 million PIPE investment to fund growth and operations.
Value
$15M
Counterparty
DEAG Deutsche Entertainment AG
“I believe one of the most significant long-term consequences of AI and robotics will be a gradual reduction in the need for human labor. And I believe people will mostly allocate this free time to shared, real live human experiences. This creates scarcity, as sports and live experiences cannot be automated or replicated by AI. A live game, a concert, a record broken in front of a crowd - all those moments create goosebumps and become more valuable as everything else becomes digitally abundant. We believe the winners will be the companies that own the content, the stage and the ticket. With DEAG, Enhanced will have all three: owned sports and live IP, a broad promoter and venue network, and proprietary ticketing. And we believe we are acquiring it at a very attractive valuation.”
Maximilian Martin, Co-Founder and Chief Executive Officer of Enhanced
For the nine months ended September 30, 2026, Silgan Holdings reported net sales of $5.24 billion, a slight increase from $5.01 billion in the prior year, while net income decreased to $243.8 million from $270.2 million. The company experienced higher rationalization charges and increased cost of goods sold, which impacted overall profitability despite the growth in sales.
Liberty Global EVP, CTO Enrique Rodriguez Buys $2M of Stock
Enrique Rodriguez, EVP, CTO, bought 211,313 shares of Liberty Global Ltd. at $9.45 a share, worth $2M in total on Nov 4, 2026. Shares held after the trade: 602,378 (+54.0%).
Liberty Global President & CEO Michael T. Fries Buys $1.03M of Stock
Michael T. Fries, President & CEO, bought 110,000 shares of Liberty Global Ltd. at $9.37 a share, worth $1.03M in total on Nov 4, 2026. Shares held after the trade: 1,238,525 (+9.7%).
First Business Financial Services Investor Presentation
First Business Financial Services, Inc. posted an updated investor presentation for the third quarter of 2026 to its website. The presentation provides an overview of the company's recent operating performance, financial condition, and business strategy for use in upcoming interactions with shareholders and analysts.
Park Ohio delivered a solid Q1 2026 with 4% revenue growth and record engineered product sales, while initiating a strategic review of its loss-making Southwest Steel Processing unit to unlock significant EPS upside.
FRP Holdings is pivoting capital toward industrial real estate while facing significant multi-family delinquency headwinds in DC and slower-than-expected industrial leasing momentum, leading to a downward revision of full-year NOI guidance.
Digital Turbine appointed Daniel Lentz as Chief Financial Officer, effective November 2, 2026. His compensation package includes a $450,000 base salary, a $100,000 signing bonus, and long-term incentive awards valued at $1.05 million split between performance-based and time-based restricted stock units.
Iovance Biotherapeutics reported significant revenue growth for the nine months ended September 30, 2026, reaching $292.2 million compared to $176.7 million in the prior year. The company successfully narrowed its net loss to $148.6 million from $319.1 million, supported by reduced research and development expenses and increased product sales.
MetaVia announced positive interim data from Part 3B of its Phase 1 trial for DA-1726, showing a statistically significant 68% placebo-adjusted reduction in liver fat and 13.5% weight loss after 16 weeks. The results support the company's plan to initiate a Phase 2 study in patients with MetALD and ALD in the second half of 2027.
“These are the most compelling clinical data we have generated to date supporting DA-1726’s potential as a liver-focused cardiometabolic therapy. A 68% placebo-adjusted reduction in liver fat after approximately 16 weeks, together with all five participants who entered the study with liver steatosis achieving MRI-PDFF below 5%, provides a strong clinical rationale for expanding DA-1726 into liver disease.”
Hyung Heon Kim, President and Chief Executive Officer
“The next step for DA-1726 is clear. We intend to build on these results by advancing the program into both metabolic dysfunction and alcohol-associated liver disease (MetALD) and alcohol-associated liver disease (ALD), where there are currently no approved therapies specifically for these patient populations.”
Hyung Heon Kim, President and Chief Executive Officer
Kartoon Studios announced that its subsidiary-sponsored SPAC, Kartoon Studios Acquisition Corp. (KSAC), has filed a registration statement for a proposed $300 million initial public offering. KSAC intends to list on the NYSE and will target business combinations in the media and entertainment sectors, managed by Kartoon Studios' senior leadership team.
AIM ImmunoTech Inc. has released a new corporate presentation titled 'The Ampligen Opportunity' along with a corresponding press release. The presentation outlines the company's strategic objectives and the clinical potential of its lead drug candidate, Ampligen, particularly in treating pancreatic cancer.
Webull President Anthony Michael Denier Sells $290K of Stock
Anthony Michael Denier, President, sold 53,846 shares of Webull Corp at $5.39 a share, worth $290K in total on Nov 4, 2026. Shares held after the trade: 2,063,065 (-2.5%).
BDX completed its transformation to a pure-play MedTech company, delivering 5.6% revenue growth in Q4 while navigating Alaris headwinds and significant tariff impacts through operational excellence and biologic drug delivery momentum.
N-able, Inc. reported 176,719,518 shares of common stock outstanding as of November 2, 2026, and is classified as a large accelerated filer. The company highlighted recent strategic activities including the acquisition of Adlumin, Inc. and an asset acquisition from Infrascale, Inc., while noting a material weakness in internal control over financial reporting identified in the second quarter of 2026.
Chatham Lodging Trust reported record Q3 2026 financial results, with RevPAR surging 8% to an all-time high of $161. Net income more than doubled to $5 million, while Adjusted FFO per diluted share grew 31% to $0.46, driven by strong performance in Silicon Valley and aggressive expense management.
Term
Q3 2026
“Operating results have been fantastic this year. Strong top-line growth and margin expansion, as well as excellent strategic decisions with respect to our repurchas”
Jeffrey H. Fisher, Chatham’s president and chief executive officer
Construction Partners, Inc. reported preliminary fiscal year 2026 results with revenue expected to reach approximately $3.67 billion, a 30% increase year-over-year. The company also introduced fiscal 2027 guidance, projecting approximately 15% growth in both revenue and Adjusted EBITDA at the midpoint of its ranges.
Term
FY2026
“Fiscal 2026 was a successful year for CPI, highlighted by record financial performance and significant year-over-year growth, with revenue increasing approximately 30%, net income rising approximately 40%, and Adjusted EBITDA growing approximately 23%.”
Fred J. (Jule) Smith, III, the Company’s President and Chief Executive Officer
“I was particularly proud of our team’s productivity and disciplined execution despite two primary external headwinds during the fourth quarter. Unusually wet weather in July across several of our largest markets, together with the unprecedented rapid pace and magnitude of increases in diesel fuel costs, affected profitability as we exited the fiscal year.”
Fred J. (Jule) Smith, III, the Company’s President and Chief Executive Officer
Malibu Boats reported net sales of $252.9 million for the quarter ended September 30, 2026, a significant increase from $194.7 million in the prior year period. The company returned to profitability with a net income of $6.1 million compared to a net loss of $0.7 million, driven by higher sales volume and lower general and administrative expenses.
Tractor Supply Company's Board of Directors declared a quarterly cash dividend of $0.24 per share of common stock. The dividend is payable on December 8, 2026, to stockholders of record as of November 23, 2026.
Victory Capital Holdings reported a significant increase in total revenue to $1.22 billion for the nine months ended September 30, 2026, compared to $932 million in the prior year period. Net income for the same nine-month period rose to $342.8 million, driven by higher investment management fees and the impact of the Amundi US acquisition.
Airship AI reported Q3 2026 net revenues of $6.23 million, a 429% increase year-over-year, and net income of $9.62 million. The company ended the quarter with a backlog of $28.3 million and a validated pipeline of approximately $215 million across its AI-driven edge and data management platforms.
Wheels Up Experience Inc. reported a net loss of $89.4 million for the third quarter of 2026, an increase from the $83.7 million loss in the prior year period, despite a decrease in total revenue to $164.8 million. The company's long-term debt significantly increased to $684.0 million as of September 30, 2026, compared to $316.4 million at the end of 2025, reflecting ongoing business transformation and fleet scaling efforts.
Airship AI Holdings reported a significant increase in net revenues to $16.7 million for the nine months ended September 30, 2026, compared to $8.8 million in the prior year. The company achieved a net income of $6.5 million for the period, largely driven by non-cash gains from the change in fair value of warrant and earnout liabilities totaling approximately $9.8 million.
Dropbox Signs $350M M&A Deal with Tigris Data Inc.
Dropbox has entered into a definitive agreement to acquire Tigris Data Inc., a globally distributed object storage platform for AI workloads, for approximately $350 million in cash. The acquisition is intended to accelerate Dropbox's expansion into AI infrastructure and supports the launch of DBX Agent Cloud, a new storage and data infrastructure offering for developers.
Myriad Genetics detected unauthorized access to its IT network on November 2, 2026, leading to a temporary suspension of testing operations and order management systems. The company has engaged external experts to investigate the scope of the breach, including potential access to patient records, though most systems have since returned to normal operations. Management currently believes the incident will not have a material adverse effect on the business.
Hudson Pacific Properties reported Q3 2026 financial results, highlighting its fifth consecutive quarter of office occupancy growth to 85.6% and the execution of 534,000 square feet of office leases. Core FFO per share grew 8% year-over-year to $0.28, while the company reduced its share of debt by 14% through asset sales and senior note repurchases.
Term
Q3 2026
“Our third quarter results build on the momentum we established last quarter. We signed more than half a million square feet of office leases, bringing our year-to-date total to 2.4 million square feet, up 40% from the first nine months of last year, and grew in-service office occupancy for the fifth consecutive quarter.”
Victor Coleman, Hudson Pacific's CEO and Chairman
“Looking ahead, our leasing pipeline remains above 2 million square feet, with more than 1 million square feet now in advanced stages, nearly twice the level of a year ago. A pipeline of similar size set the stage for a very strong 2026, and the greater maturity of today’s pipeline further positions us to extend our earnings growth into 2027.”
HCW Biologics $10.2M Debt Financing with Streeterville Capital, LLC
HCW Biologics entered into a Notes Purchase Agreement for the issuance of two secured promissory notes totaling $10.2 million in principal ($3.2M A-1 Note and $7.0M B Note). The financing provides immediate net proceeds of approximately $3.0 million, with the remaining $7.0 million held in a restricted account to be released as the A-1 Note is repaid. Proceeds will fund the Phase 1 clinical study of HCW9302 for alopecia areata through its expected readout in Q1 2027.
Immunic, Inc. is hosting a Progressive Multiple Sclerosis (PMS) Research and Development Day webinar on November 5, 2026. The company filed a formal investor presentation deck (Exhibit 99.1) to be used during the event, covering its development programs and clinical data for vidofludimus calcium.